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Research
Correspondence Elevation of Parathyroid Hormone Levelsin Atrial FibrillationTo the Editor: Atrial fibrillation (AF) is the most common cardiac
arrhythmia, as well as an important cause of cardiovascular
morbidity and mortality. Despite an extensive search for contrib-
utors to AF risk, a substantial portion of the variability in AF risk
remains unexplained.
Parathyroid hormone (PTH) receptors are expressed throughout
the cardiovascular system, including in the heart, where PTH acts as
a cardiac hormone with a diverse array of effects (1). Parathyroid
hormone accelerates heart rate, an effect that may be mediated by
direct action of PTH on the sinus node and conducting system; and
PTH also exerts inotropic effects, possibly as a consequence of
increased coronary blood flow due to the vasodilatory action of PTH
on the coronary circulation (2). Several experimental and clinical
studies reported that PTH is associated with hypertension, distur-
bances in the renin-angiotensin-aldosterone system, ventricular fibril-
lation, left ventricular hypertrophy, and heart failure, as well as
structural and functional changes in the vascular wall (1).
Given the associations between PTH and several AF risk factors,
e hypothesized that PTH levels are altered in subjects with AF.
Consecutive subjects with AF were prospectively enrolled be-
ween 2001 and 2005 from the Cardiac Arrhythmia Service.
nclusion criteria were electrocardiography documented AF, age
ounger than 66 years, and a structurally normal heart on echo-
ardiography. Subjects were excluded if they had significant valve
isease, a history of rheumatic heart disease, congenital heart
isease, cardiomyopathy, myocarditis, or thyrotoxicosis. Subjects
ree of hypertension were considered to have lone AF. Control
ubjects, with comparable age and sex distribution, were selected
rom a healthy primary care population (Global Repository,
enomics Collaborative, Inc., Cambridge, Massachusetts). All
tudies were performed with institutional review board approval
nd written informed consent from each subject.
All AF subjects underwent a structured interview to elicit a
etailed medical history, physical examination, electrocardiogra-
hy, and echocardiography. Subjects with AF of 6 months in
uration and 1 attempted electrical cardioversion were consid-
red to have permanent AF. All other subjects were considered to
ave paroxysmal AF.
Plasma PTH levels were determined using an enzyme immu-
oassay (Biomedica Gruppe, Vienna, Austria). All samples were
erformed in duplicate, and values were normalized to a standard
urve. The intra-assay and interassay variabilities for PTH were
.0% and 5.1%, respectively.
The study cohort consisted of 380 subjects (230 with AF and
50 control subjects). The mean age was 56  11 years. Eighty
ercent were male, 88% had paroxysmal AF. The AF group
onsisted of 144 subjects with lone AF and 86 with AF and
ypertension. Subjects with AF and hypertension were older than
ubjects with lone AF (60  9 years vs. 53  11 years, respec-
tively), had higher blood pressures (systolic 138  19 mm Hg vs.123  13 mm Hg, p  0.001, and diastolic 82  10 mm Hg vs.
76  8 mm Hg, respectively, p  0.001), and body mass index
(30  6 kg/m2 vs. 27  4 kg/m2, respectively, p  0.001), and
were more likely to have received antihypertensive medication.
There were no electrocardiographic and echocardiographic abnor-
malities in either AF group.
The PTH levels were higher in AF subjects compared with
those of controls (56 pg/ml [38 to 72 pg/ml] vs. 50 pg/ml [36 to
65 pg/ml], p  0.01) (Fig. 1). There was a progressive increase in
PTH levels among the controls, lone AF, and AF and hyperten-
sion (50 pg/ml [36 to 65 pg/ml], 54 pg/ml [39 to 69 pg/ml], and
59 pg/ml [37 to 81 pg/ml], respectively, p  0.03). At the time of
blood sampling, 203 subjects were diagnosed with paroxysmal AF
and 27 with permanent AF. The PTH levels were higher in
permanent AF subjects as compared with paroxysmal AF subjects (61
pg/ml [52 to 91 pg/ml] vs. 55 pg/ml [37 to 71 pg/ml], p 0.03), and
higher in paroxysmal AF subjects compared with controls (55 pg/ml
[37 to 71 pg/ml] vs. 50 pg/ml [36 to 65 pg/ml], p  0.046). At the
time of blood sampling, 164 subjects were in sinus rhythm and 50
were in AF; PTH levels were higher in AF compared to sinus rhythm
(64 pg/ml [44 to 87 pg/ml] vs. 54 pg/ml [38 to 70 pg/ml], p 0.001),
and no significant difference between sinus rhythm and controls was
found (54 pg/ml [38 to 70 pg/ml] vs. 50 pg/ml [36 to 65 pg/ml], p
0.08). Multivariable regression modeling of the AF cohort revealed
that each millimeter increase in left atrial size was associated with a
0.23 0.01 pg/ml increase per SD of log(PTH) levels (mean 1.72
0.21; p  0.047).
We observed that PTH levels are higher in subjects with AF. This
elevation is most prominent in subjects with AF and hypertension,
subjects with permanent AF, and subjects who were in AF during
blood sampling. Our data suggest that both the rhythm itself and
hypertension may play a role in determining PTH levels.
Our findings are consistent with earlier findings that PTH is
reported to be associated with hypertension and left ventricular
hypertrophy (1). Whether stimulation of vascular smooth muscle
cells by increased intracellular cAMP-levels and reduced influx of
calcium, or impaired endothelium-dependent vasodilation, or stiff-
ening of the arteries leading to impaired hemodynamics by chronic
hypercalcemia plays a role as a result of PTH is uncertain.
The PTH levels were higher in subjects in AF at the time of
blood draw compared to levels in subjects in sinus rhythm, and the
highest levels were found in subjects with permanent AF compared
to paroxysmal AF. Furthermore, we found an association between
left atrial size and PTH. These observations may implicate AF as
a causal factor for PTH elevation. Potentially, the hemodynamic
consequences of AF, including the loss of atrial contraction, atrial
volume, and pressure overload, atrial stretch, and the 10% to 20%
decrease of cardiac output, may be the underlying mechanism.
Previously, data have been reported that PTH-related protein
messenger ribonucleic acid expression increased in the rat heart as
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June 21, 2011:2542–6result of physiologic maneuvers that increase atrial or ventricular
workload and distention (2). Also, a decline in elevated PTH-
related peptide levels was observed directly after electrical cardio-
version in patients with new-onset AF (3).
Our study is cross-sectional in design, which precludes definite
onclusions regarding a cause-effect relationship. Future studies
ill be necessary to delineate the temporal relation between AF
nd PTH levels.
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Letters to the Editor
Prognostic Value
of Cardiac Computed
Tomography Angiography
We read with interest the systematic review and meta-analysis
reporting on the prognostic value of cardiac computed tomography
rillation (AF) and (B) lone AF versus AF and hypertension, (C)
show interquartile ranges, and bars represent the 90th and 10th percentiles.trial fib
oxesangiography (CCTA) by Hulten et al. (1). The authors performed
